Inhibition of interleukin 17 production by curcumin in mice with collagen-induced arthritis

Biomedical Research

Volumn 22, Issue 3, 2011, Pages 299-304

  Okamoto, Yoshihiro ^a   Tanaka, Mayuri ^a   Fukui, Takashi ^a   Masuzawa, Toshiyuki ^a  

^a CHIBA INSTITUTE OF SCIENCE   (Japan)

Author keywords

Collagen induced arthritis (CIA); Curcumin; Interleukin 17 (IL 17)

Indexed keywords

COLLAGEN; CURCUMIN; INTERLEUKIN 17;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG ACTIVITY; FEMALE; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RHEUMATOID ARTHRITIS; SPLEEN CELL; THERAPY EFFECT; TREATMENT DURATION;

ANIMALIA; CUMINUM CYMINUM; CURCUMA LONGA; MUS;

EID: 79960760650     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joos-ten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004;50(2):650-9.
2. Nakae S, Nambu A, Sudo K, Iwakura Y. Sup-pression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Im-munol 2003;171(11):6173-7.
3. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13(2):139-45.
4. Lubberts E. Th17 cytokines and arthritis. Semin Immunopathol 2010;32(1):43-53.
5. Sharma RA, Gescher AJ, Steward WP. Curcu-min: the story so far. Eur J Cancer 2005;41(13):1955-68.
6. Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, et al. Turmeric extracts contain-ing curcuminoids prevent experimental rheu-matoid arthritis. J Nat Prod 2006;69(3):351-5.
7. Jagetia GC, Aggarwal BB. Spicing up of the immune system by curcumin. J Clin Immunol 2007;27(1):19-35.
8. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23(1A):363-98.
9. Moon DO, Kim MO, Choi YH, Park YM, Kim GY. Curcumin attenuates inflammatory re-sponse in IL-1beta-induced human synovial fi-broblasts and collagen-induced arthritis in mouse model. Int Immunopharmacol 2010;10(5):605-10.
10. Mun SH, Kim HS, Kim JW, Ko NY, Kim do K, Lee BY, et al. Oral administration of curcumin suppresses production of matrix metallopro-teinase (MMP)-1 and MMP-3 to ameliorate col-lagen-induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway. J Pharmacol Sci 2009;111(1):13-21.
11. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterolo-gous type II collagen induces arthritis in mice. Nature 1980;283(5748):666-8.
12. Wood FD, Pearson CM, Tanaka A. Capacity of mycobacterial wax D and its subfractions to in-duce adjuvant arthritis in rats. Int Arch Allergy Appl Immunol 1969;35(5):456-67.
13. Pappu BP, Dong C. Measurement of inter-leukin-17. Curr Protoc Immunol 2007;Chapter 6: Unit 6 25.
14. Okamoto Y, Abe T, Niwa T, Mizuhashi S, Ni-shida M. Development of a dual color enzyme-linked immunospot assay for simultaneous de-tection of murine T helper type 1- and T helper type 2-cells. Immunopharmacology 1998; 39 (2): 107-116.
15. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci 2006;78(18):2081-7.
16. Harrington LE, Mangan PR, Weaver CT. Ex-panding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006; 18(3): 349-56.
17. Yamaguchi Y, Fujio K, Shoda H, Okamoto A, Tsuno NH, Takahashi K, et al. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflamma-tory arthritis. J Immunol 2007;179(10):7128-36.
18. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. Faseb J 1991;5(2):171-7.
19. Mosmann TR, Coffman RL. TH1 and TH2 cells:different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
20. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6(11):1123-32.
21. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cyto-kine 2008;41(2):84-91.
22. Bengmark S, Mesa MD, Gil A. Plant-derived health: the effects of turmeric and curcuminoids. Nutr Hosp 2009;24(3):273-81.
23. Bremner P, Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmacol 2002;54(4):453-72.
24. Seetharaman R, Mora AL, Nabozny G, Boothby M, Chen J. Essential role of T cell NF-kappa B activation in collagen-induced arthritis. J Im-munol 1999;163(3):1577-83.
25. Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, Heo SB, et al. STAT3 and NF-kappaB sig-nal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 2006;176(9):5652-61.
26. Blasius R, Reuter S, Henry E, Dicato M, Died-erich M. Curcumin regulates signal transducer and activator of transcription (STAT) expres-sion in K562 cells. Biochem Pharmacol 2006;72(11):1547-54.
27. Liu YC, Hsieh CW, Wu CC, Wung BS. Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous elec-trophile. Life Sci 2007;80(15):1420-30.
28. Xie L, Li XK, Funeshima-Fuji N, Kimura H, Matsumoto Y, Isaka Y, et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol 2009;9(5): 575-81.